Determine the rate of acceptance of pharmaceutical
Showing 1 - 25 of >10,000
HIV Testing Rate, Acceptance of Immediate ART Trial in Pathum Wan
Completed
- HIV Testing Rate
- Acceptance of Immediate ART
-
Pathum Wan, Bangkok, ThailandThe Thai Red Cross AIDS Research Centre
Jul 8, 2021
Allograft Trial in Limoges (pharmaceutical follow-up)
Recruiting
- Allograft
- pharmaceutical follow-up
-
Limoges, FranceLimoges University Hospital
May 30, 2022
Essential Hypertension Trial (Nerkardou 5 mg & Nerkardou 10 mg)
Not yet recruiting
- Essential Hypertension
- Nerkardou 5 mg & Nerkardou 10 mg
- (no location specified)
May 30, 2023
Treatment Satisfaction, Participation Rate, Patient, Quality of Life Trial (Mindfulness-based stress reduction (MBSR), Treatment
Terminated
- Treatment Satisfaction
- +5 more
- Mindfulness-based stress reduction (MBSR)
- Treatment as usual (TAU)
- (no location specified)
Feb 21, 2022
End Stage Renal Disease Trial (Behavioral Patient care)
Withdrawn
- End Stage Renal Disease
- Behavioral Patient care
- (no location specified)
Jul 17, 2023
Cancer Trial (Geriatric oncology tele-consultation and pharmaceutical tele-expertise)
Not yet recruiting
- Cancer
- Geriatric oncology tele-consultation and pharmaceutical tele-expertise
- (no location specified)
Nov 9, 2022
Hypertension Trial (Pharmaceutical care via telepharmacy and usual care, Pharmaceutical care in-person and usual care)
Not yet recruiting
- Hypertension
- Pharmaceutical care via telepharmacy and usual care
- Pharmaceutical care in-person and usual care
- (no location specified)
Nov 1, 2023
Healthy Individuals, Bioequivalence Study Trial in Karachi (Moxifloxacin 400mg)
Completed
- Healthy Individuals
- Bioequivalence Study
- Moxifloxacin 400mg
-
Karachi, Sindh, PakistanCenter for Bioequivalence Studies and clinical research
Sep 5, 2022
Healthy, Bioequivalence Study Trial in Karachi (Dexlansoprazole)
Recruiting
- Healthy
- Bioequivalence Study
-
Karachi, Sindh, PakistanCenter for Bioequivalence Studies and clinical research
Sep 5, 2022
Acute Respiratory Distress Syndrome Trial in China (STC314 injection or Placebo(rate=58.3 mg/hr), STC314 injection or
Recruiting
- Acute Respiratory Distress Syndrome
- STC314 injection or Placebo(rate=58.3 mg/hr)
- STC314 injection or Placebo(rate=87.5 mg/hr)
-
Shijiazhuang, Hebei, China
- +4 more
Dec 23, 2021
Optimizing Pharmacotherapy of Vascular Surgery Patients at
Recruiting
- Medication Errors and Other Product Use Errors and Issues
-
Bratislava, SlovakiaNational Institute of Cardiovascular Diseases, Slovakia
Jul 5, 2022
Stroke Trial in Istanbul (Clinical Pharmacist Led Pharmaceutical Care)
Completed
- Stroke
- Clinical Pharmacist Led Pharmaceutical Care
-
Istanbul, TurkeyMarmara University Pendik Research and Training Hospital
Nov 8, 2023
Prematurity Trial in Canada (CCENT Intervention)
Active, not recruiting
- Prematurity
- CCENT Intervention
-
Vancouver, British Columbia, Canada
- +6 more
Nov 1, 2022
Allergic Rhinitis, Pharmaceutical Care, Pharmaceutical Services Trial in Ipoh (pharmacist-led education)
Recruiting
- Allergic Rhinitis
- +2 more
- pharmacist-led education
-
Ipoh, Perak, MalaysiaRaja Permaisuri Bainun Hospital
Aug 30, 2023
Behavior, Child, Dental Anxiety, Anesthesia, Local Trial in Damascus (Evaluation the effectiveness of distraction in the
Recruiting
- Behavior, Child
- +2 more
- Evaluation the effectiveness of distraction in the reception area in the management of anxious pediatric patients during dental local anesthesia
- +3 more
-
Damascus, Syrian Arab RepublicDamascus University
Nov 3, 2023
Epilepsy Trial in Lille (Pharmacist intervention, Standard of care)
Recruiting
- Epilepsy
- Pharmacist intervention
- Standard of care
-
Lille, FranceHopital Roger Salengro, CHU Lille
Nov 8, 2022
Parents, Stress, Psychological, Anxiety Trial in Stockholm (I-Navigator ACT, Navigator ACT group)
Active, not recruiting
- Parents
- +9 more
- I-Navigator ACT
- Navigator ACT group
-
Stockholm, Region Stockholm, SwedenHabilitering & Hälsa
Jul 3, 2023
Chronic Heart Failure Trial (ACT (Acceptance and Commitment Therapy), HE (Health Education))
Recruiting
- Chronic Heart Failure
- ACT (Acceptance and Commitment Therapy) plus brief CHF education
- HE (Health Education)
-
Shiyan, Hubei, ChinaTaihe Hospital
Nov 9, 2022
Gastric Cancer, NSCLC, Colo-rectal Cancer Trial in Changchun (Ramucirumab Injection, Ramucirumab Injection [Cyramza])
Completed
- Gastric Cancer
- +2 more
- Ramucirumab Injection
- Ramucirumab Injection [Cyramza]
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Mar 24, 2023
Pneumonia, Pneumococcal, Vaccine Trial (Pneumococcal Vaccine Education)
Not yet recruiting
- Pneumonia, Pneumococcal
- Vaccine
- Pneumococcal Vaccine Education
- (no location specified)
Nov 13, 2023
Trauma Trial (4FM Acceptance Training)
Not yet recruiting
- Trauma
- 4FM Acceptance Training
- (no location specified)
Dec 29, 2022
Behavior, Child, Dental Anxiety, Anesthesia, Local Trial in Damascus (Evaluation of the effectiveness of eye massage device
Recruiting
- Behavior, Child
- +2 more
- Evaluation of the effectiveness of eye massage device producing both vibrations and nature sounds distraction in the management of anxious pediatric patients during inferior alveolar nerve.
- +2 more
-
Damascus, Syrian Arab RepublicDamascus University
Oct 21, 2022